| Literature DB >> 29413501 |
Nicolas Guibert1, Laurent Mhanna2, Alain Didier3, Benjamin Moreno4, Pierre Leyx5, Gavin Plat6, Julien Mazieres7, Christophe Hermant8.
Abstract
New 3D technologies are rapidly entering into the surgical landscape, including in interventional pulmonology. The transition of 2D restricted data into a physical model of pathological airways by three-dimensional printing (3DP) allows rapid prototyping and fabrication of complex and patient-specific shapes and can thus help the physician to plan and guide complex procedures. Furthermore, computer-assisted designed (CAD) patient-specific devices have already helped surgeons overcome several therapeutic impasses and are likely to rapidly cover a wider range of situations. We report herein with a special focus on our clinical experience: i) how additive manufacturing is progressively integrated into the management of complex central airways diseases; ii) the appealing future directions of these new technologies, including the potential of the emerging technique of bioprinting; iii) the main pitfalls that could delay its introduction into routine care.Entities:
Keywords: 3D printing; Additive manufacturing; Central airway obstruction; Computer-assisted design; Interventional bronchoscopy
Mesh:
Year: 2017 PMID: 29413501 DOI: 10.1016/j.rmed.2017.11.019
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415